Anixa Biosciences (ANIX) Cash Flow: Operating & Free Cash Flow

Anixa Biosciences Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Anixa Biosciences, Inc. (ANIX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Oct 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021	Oct 2020	Oct 2019	Oct 2018	Oct 2017
Operating Activities
Net Income	-11.03	-12.70	-9.93	-13.77	-13.13	-10.09	-11.82	-14.24	-5.01
Depreciation & Amortization	0.04	0.04	0.05	0.04	0.06	0.09	0.47	0.34	0.37
Stock Based Compensation	3.81	4.42	4.42	6.00	8.06	3.92	5.71	8.58	1.67
Change in Working Capital	0.15	0.53	-1.06	0.49	0.08	-0.46	0.48	0.07	0.41
Change in Accounts Receivable	0.17	0.10	-0.22	-0.03	0.00	0.06	0.27	-0.26	0.00
Change in Inventory	0.00	0.00	0.00	0.00	0.00	-0.06	-0.27	0.00	0.00
Change in Accounts Payable	-0.36	0.32	-0.06	0.13	-0.10	-0.35	0.00	0.10	0.11
Change in Other Working Capital	0.52	0.11	-0.78	0.39	-0.02	-0.11	0.47	0.23	0.30
Other Operating Activities	-0.14	0.38	0.31	0.75	-0.01	0.36	0.42	0.98	-1.24
Net Cash from Operating Activities	-7.17	-7.34	-6.21	-6.49	-4.94	-6.18	-4.74	-4.27	-3.80
Investing Activities
Capital Expenditures	0.00	0.00	0.00	0.00	0.00	-0.02	-0.18	-0.04	-0.03
Acquisitions	0.00	0.00	0.00	0.00	0.01	5.01	3.85	0.00	0.00
Purchases of Investments	-44.36	-63.77	-44.41	-22.49	-3.96	-5.01	-3.85	-4.25	-5.50
Sales/Maturities of Investments	49.23	68.05	38.81	11.76	12.54	4.72	3.50	5.75	2.75
Other Investing Activities	0.00	0.00	0.00	0.00	0.01	-5.01	-3.85	0.00	0.05
Net Cash from Investing Activities	4.87	4.28	-5.60	-10.73	-3.92	-0.31	-0.53	1.46	-2.74
Financing Activities
Debt Repayment	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-3.00
Common Stock Issued	2.28	2.96	0.00	0.00	31.57	9.27	5.53	2.47	10.88
Common Stock Repurchased	0.00	-0.01	0.00	0.00	0.00	0.00	0.00	0.00	-0.50
Other Financing Activities	-0.11	0.47	0.37	0.45	0.44	0.14	0.18	0.06	-0.49
Net Cash from Financing Activities	2.28	3.42	0.37	0.45	31.57	9.41	5.70	2.53	7.38
Summary
Net Change in Cash	-0.03	0.36	-11.45	-16.77	22.71	2.93	0.44	-0.28	0.85
Cash at Beginning of Period	1.27	0.92	12.36	29.13	6.42	3.49	3.06	3.34	2.49
Cash at End of Period	1.24	1.27	0.92	12.36	29.13	6.42	3.49	3.06	3.34
Free Cash Flow	-7.17	-7.34	-6.21	-6.49	-4.94	-6.19	-4.92	-4.31	-3.83

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Anixa Biosciences Cash Flow

What is Anixa Biosciences's free cash flow?

Anixa Biosciences had negative free cash flow of $7.17M in fiscal 2025 (fiscal year ended Oct 31, 2025).

Does Anixa Biosciences pay dividends or buy back shares?

Anixa Biosciences's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition